Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1954 1
1955 1
1956 2
1957 1
1958 1
1959 4
1960 3
1961 2
1962 2
1964 3
1965 1
1967 1
1970 2
1971 6
1972 4
1973 1
1974 3
1975 2
1976 2
1977 3
1978 4
1979 2
1980 2
1981 1
1982 4
1983 3
1984 5
1985 5
1986 2
1987 3
1988 3
1989 1
1990 7
1991 2
1992 5
1993 2
1994 4
1995 6
1996 3
1997 9
1998 2
1999 5
2000 6
2001 2
2002 2
2003 3
2004 1
2005 1
2006 1
2009 2
2010 4
2011 5
2012 6
2013 6
2014 3
2015 3
2016 4
2017 2
2018 8
2019 4
2020 8
2021 6
2022 4
2023 5
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

198 results

Results by year

Filters applied: . Clear all
Page 1
Empagliflozin in Patients with Chronic Kidney Disease.
The EMPA-KIDNEY Collaborative Group; Herrington WG, Staplin N, Wanner C, Green JB, Hauske SJ, Emberson JR, Preiss D, Judge P, Mayne KJ, Ng SYA, Sammons E, Zhu D, Hill M, Stevens W, Wallendszus K, Brenner S, Cheung AK, Liu ZH, Li J, Hooi LS, Liu W, Kadowaki T, Nangaku M, Levin A, Cherney D, Maggioni AP, Pontremoli R, Deo R, Goto S, Rossello X, Tuttle KR, Steubl D, Petrini M, Massey D, Eilbracht J, Brueckmann M, Landray MJ, Baigent C, Haynes R. The EMPA-KIDNEY Collaborative Group, et al. N Engl J Med. 2023 Jan 12;388(2):117-127. doi: 10.1056/NEJMoa2204233. Epub 2022 Nov 4. N Engl J Med. 2023. PMID: 36331190 Free PMC article. Clinical Trial.
Condition-dependent transcriptome reveals high-level regulatory architecture in Bacillus subtilis.
Nicolas P, Mäder U, Dervyn E, Rochat T, Leduc A, Pigeonneau N, Bidnenko E, Marchadier E, Hoebeke M, Aymerich S, Becher D, Bisicchia P, Botella E, Delumeau O, Doherty G, Denham EL, Fogg MJ, Fromion V, Goelzer A, Hansen A, Härtig E, Harwood CR, Homuth G, Jarmer H, Jules M, Klipp E, Le Chat L, Lecointe F, Lewis P, Liebermeister W, March A, Mars RA, Nannapaneni P, Noone D, Pohl S, Rinn B, Rügheimer F, Sappa PK, Samson F, Schaffer M, Schwikowski B, Steil L, Stülke J, Wiegert T, Devine KM, Wilkinson AJ, van Dijl JM, Hecker M, Völker U, Bessières P, Noirot P. Nicolas P, et al. Among authors: samson f. Science. 2012 Mar 2;335(6072):1103-6. doi: 10.1126/science.1206848. Science. 2012. PMID: 22383849
Detailed genetic characteristics of an international large cohort of patients with Stargardt disease: ProgStar study report 8.
Fujinami K, Strauss RW, Chiang JP, Audo IS, Bernstein PS, Birch DG, Bomotti SM, Cideciyan AV, Ervin AM, Marino MJ, Sahel JA, Mohand-Said S, Sunness JS, Traboulsi EI, West S, Wojciechowski R, Zrenner E, Michaelides M, Scholl HPN; ProgStar Study Group; ProgStar Study Group. Fujinami K, et al. Br J Ophthalmol. 2019 Mar;103(3):390-397. doi: 10.1136/bjophthalmol-2018-312064. Epub 2018 Jun 20. Br J Ophthalmol. 2019. PMID: 29925512 Free PMC article.
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial.
Baigent C, Landray MJ, Reith C, Emberson J, Wheeler DC, Tomson C, Wanner C, Krane V, Cass A, Craig J, Neal B, Jiang L, Hooi LS, Levin A, Agodoa L, Gaziano M, Kasiske B, Walker R, Massy ZA, Feldt-Rasmussen B, Krairittichai U, Ophascharoensuk V, Fellström B, Holdaas H, Tesar V, Wiecek A, Grobbee D, de Zeeuw D, Grönhagen-Riska C, Dasgupta T, Lewis D, Herrington W, Mafham M, Majoni W, Wallendszus K, Grimm R, Pedersen T, Tobert J, Armitage J, Baxter A, Bray C, Chen Y, Chen Z, Hill M, Knott C, Parish S, Simpson D, Sleight P, Young A, Collins R; SHARP Investigators. Baigent C, et al. Lancet. 2011 Jun 25;377(9784):2181-92. doi: 10.1016/S0140-6736(11)60739-3. Epub 2011 Jun 12. Lancet. 2011. PMID: 21663949 Free PMC article. Clinical Trial.
Hyperlexia: Systematic review, neurocognitive modelling, and outcome.
Ostrolenk A, Forgeot d'Arc B, Jelenic P, Samson F, Mottron L. Ostrolenk A, et al. Among authors: samson f. Neurosci Biobehav Rev. 2017 Aug;79:134-149. doi: 10.1016/j.neubiorev.2017.04.029. Epub 2017 May 3. Neurosci Biobehav Rev. 2017. PMID: 28478182 Free article. Review.
AI-based mobile application to fight antibiotic resistance.
Pascucci M, Royer G, Adamek J, Asmar MA, Aristizabal D, Blanche L, Bezzarga A, Boniface-Chang G, Brunner A, Curel C, Dulac-Arnold G, Fakhri RM, Malou N, Nordon C, Runge V, Samson F, Sebastian E, Soukieh D, Vert JP, Ambroise C, Madoui MA. Pascucci M, et al. Among authors: samson f. Nat Commun. 2021 Feb 19;12(1):1173. doi: 10.1038/s41467-021-21187-3. Nat Commun. 2021. PMID: 33608509 Free PMC article.
Enhanced visual functioning in autism: an ALE meta-analysis.
Samson F, Mottron L, Soulières I, Zeffiro TA. Samson F, et al. Hum Brain Mapp. 2012 Jul;33(7):1553-81. doi: 10.1002/hbm.21307. Epub 2011 Apr 4. Hum Brain Mapp. 2012. PMID: 21465627 Free PMC article. Review.
198 results